Excess risk of subsequent malignant neoplasms in adolescent and young adult cancer survivors: Results from the first Italian population-based cohort
- PMID: 34582036
- DOI: 10.1002/cncr.33931
Excess risk of subsequent malignant neoplasms in adolescent and young adult cancer survivors: Results from the first Italian population-based cohort
Abstract
Background: Evidence about late effects in adolescent and young adult (AYA) cancer survivors is scarce. This study assessed the risk of subsequent malignant neoplasms (SMNs) to identify the most common SMNs to be considered in follow-up care.
Methods: Population-based cancer registries retrospectively identified first primary tumors (between 1976 and 2013) and SMNs in AYAs (15-39 years old at their cancer diagnosis). AYA cancer survivors were those alive at least 5 years after their first cancer diagnosis. The excess risk of SMNs was measured as standardized incidence ratios (SIRs) and absolute excess risk together with the cumulative incidence of SMNs.
Results: The cohort included 67,692 AYA cancer survivors. The excess risk of developing any SMN (SIR, 1.6; 95% confidence interval, 1.5-1.7) was 60%. The excess risk of SMNs was significantly high for survivors of lymphomas; cancers of the breast, thyroid, female genital tract, digestive organs, gonads, and urinary tract; and melanomas. The cumulative incidence of all SMNs in AYA cancer survivors within 25 years of their first cancer diagnosis was approximately 10%. Subsequent tumors contributing to approximately 60% of all SMNs were breast cancer, colorectal cancer, corpus uteri cancer, and ovarian cancer in females and colorectal cancer, bladder cancer, prostate cancer, lung cancer, and lymphomas in males.
Conclusions: These results highlight the need to personalize follow-up strategies for AYA cancer survivors.
Keywords: adolescents; cancer survivors; follow-up; registries; young adult.
© 2021 American Cancer Society.
References
-
- Reports on care quality for adolescent and young adult cancer patients are lacking in the literature. European Society for Medical Oncology. Published September 14, 2017. Accessed March 11, 2021. https://www.esmo.org/oncology-news/Reports-on-Care-Quality-for-Adolescen...
-
- Adolescent and Young Adult Oncology Progress Report Group. Closing the Gap: Research and Care Imperatives for Adolescents and Young Adults With Cancers. US Department of Health and Human Services; 2006.
-
- Bleyer A. Latest estimates of survival rates of the 24 most common cancers in adolescent and young adult Americans. J Adolesc Young Adult Oncol. 2011;1:37-42.
-
- Smith MA, Altekruse SF, Adamson PC, Reaman GH, Seibel NL. Declining childhood and adolescent cancer mortality. Cancer. 2014;120:2497-2506.
-
- Trama A, Bernasconi A, McCabe MG, et al. Is the cancer survival improvement in European and American adolescent and young adults still lagging behind that in children? Pediatr Blood Cancer. 2019;66:e27407.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical